Capecitabine in Metastatic Breast and GI Cancers

Clinical trial NCT02595320 · UNKNOWN

Trial details

NCT number: NCT02595320
Sponsor: Qamar Khan
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Gastrointestinal Cancer

Start date: 2015-10-05
Primary completion: 2022-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.